Acute kidney injury
Overview
Causes of AKI by category
| Feature | Pre-renal | Intrinsic | Post-renal |
|---|---|---|---|
| Mechanism | Reduced renal perfusion | Direct kidney damage (ATN, AIN, HUS, glomerulonephritis) | Obstruction (e.g. posterior urethral valves) |
| FENa | <1% | >2% | Variable |
| Urine osmolality | >500 mOsm/kg | Low | Variable |
•Acute interstitial nephritis (AIN): drug exposure (most commonly penicillins) → T-lymphocyte infiltration of renal interstitium → cytokine release → interstitial oedema and tubular dysfunction → impaired potassium secretion → hyperkalaemia
•HUS in children: Shiga toxin-producing E. coli O157:H7 → microangiopathic haemolytic anaemia + thrombocytopenia + AKI
Presentation
•Oliguria/anuria - urine output <0.5 mL/kg/hour; abrupt anuria suggests obstruction or severe glomerulonephritis
•Oedema and hypertension - fluid overload; particularly in intrinsic causes
•Rash, fever, arthralgia - triad suggesting AIN or systemic vasculitis
•Pallor with bloody diarrhoea in a young child - classic HUS presentation
•Haematuria - suggests glomerulonephritis, HUS, or renal vein thrombosis
Investigations
🥇 First-line
•Serum U&Es - confirm AKI, stage severity, detect hyperkalaemia and acidosis
•Urine dipstick - blood/protein → glomerulonephritis; leucocytes → infection or AIN; sterile pyuria + eosinophiluria → AIN
•FBC and blood film - eosinophilia → AIN; anaemia + thrombocytopenia + schistocytes → HUS
•VBG - assess metabolic acidosis
•Renal ultrasound - mandatory if obstruction suspected; identifies hydronephrosis
🥈 Second-line
•FENa - <1% pre-renal; >2% ATN/intrinsic
•Immunological screen (ANCA, anti-GBM, complement C3/C4, ANA) - if glomerulonephritis or vasculitis suspected
🏆 Gold standard
•Renal biopsy - unexplained AKI with normal imaging, suspected glomerulonephritis/vasculitis
Management
🥇 First-line
•Identify and treat underlying cause - treat sepsis, relieve obstruction, withhold nephrotoxic drugs (NSAIDs, ACE inhibitors, ARBs, aminoglycosides)
•Fluid resuscitation in hypovolaemia - IV isotonic crystalloid 10 mL/kg bolus; reassess frequently
•Treat hyperkalaemia urgently - calcium gluconate (cardioprotection), insulin/dextrose (drive K⁺ into cells), salbutamol nebulised
🥈 Second-line
•Furosemide - ONLY for fluid overload; do NOT use routinely to treat AKI or increase urine output
🥉 Third-line
•Renal replacement therapy (RRT) - haemodialysis or CVVHF in PICU for refractory hyperkalaemia, severe acidosis, pulmonary oedema unresponsive to diuretics, or Stage 3 AKI with oligoanuria
Complications
•Hyperkalaemia - most common and most urgent electrolyte complication; risk of life-threatening arrhythmia
•Metabolic acidosis - worsens hyperkalaemia by driving K⁺ out of cells
•Pulmonary oedema - fluid overload; may cause respiratory failure
•Uraemia - encephalopathy, pericarditis, coagulopathy; indicates need for RRT
•CKD - particularly after severe or recurrent AKI
Acute Interstitial Nephritis - Exam-Favourite Pattern
•Presents 7-10 days after starting the culprit drug
•Classic triad: fever, rash, arthralgia
•Eosinophilia on FBC
•Sterile pyuria (raised urinary white cells) on dipstick
•Rising creatinine without obvious pre-renal or post-renal cause
•Most common culprit drugs: penicillins (especially amoxicillin), NSAIDs, PPIs, sulfonamides
Indications for Immediate Nephrology Referral
•K⁺ ≥6.5 mmol/L
•Oliguria with serum sodium ≤125 mmol/L
•Pulmonary oedema or hypertension unresponsive to diuretics
•Plasma urea >40 mmol/L unresponsive to fluid challenge